Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic launches Virono®- the first single-dose over-the-counter cold sore tablet
Regulatory Filings Classification · 90% confidence The document is a corporate press release announcing the commercial launch of a new OTC product (Virono®). It contains no financial results, no management or board changes, no regulatory filings or report attachments, and no earnings data. It is not soliciting votes, nor is it a proxy, dividend notice, or an actual financial report. It fits best into the fallback category for general regulatory/stock‐exchange announcements and miscellaneous corporate news: Regulatory Filings (RNS).
2026-05-21 English
Major shareholder disclosure in Navamedic ASA - Attachment: 2026-05-20_major_shareholder_disclosure.pdf
Major Shareholding Notification Classification · 95% confidence The document is a standard ESMA notification form entitled “Notification of Major Holdings”, detailing percentage of voting rights, threshold crossed, and shareholding changes by Skandinaviska Enskilda Banken. This matches the definition of a Major Shareholding Notification for changes in significant ownership levels. Hence it should be classified as MRQ.
2026-05-20 English
Major shareholder disclosure in Navamedic ASA
Major Shareholding Notification Classification · 95% confidence The text is a brief notice titled “Major shareholder disclosure,” pointing to an attachment for details. This matches a notification of significant share ownership levels crossing thresholds. It is not the full disclosure but an announcement, so classify as a Major Shareholding Notification (MRQ).
2026-05-20 English
Flaggemelding Navamedic ASA
Major Shareholding Notification Classification · 85% confidence The document is a ‘flagging notification’ (in Norwegian ‘Flaggemelding’) by a major shareholder (Kistefos AS) informing the market of its shareholding level in Navamedic ASA. It reports the total shares held and percentage ownership, matching the definition of a Major Shareholding Notification. This is not an internal management change, financial report, nor dividend notice, but a substantial shareholding disclosure.
2026-05-19 Norwegian Bokmål
Navamedic ASA: Mandatory notification of trade - Attachment: Navamedic ASA - Mandatory notification of trade.pdf
Director's Dealing Classification · 92% confidence The document is a notification under Market Abuse Regulation Article 19 of transactions by a person discharging managerial responsibilities (Chief Operating Officer) in the company’s shares, providing details of insider share purchase. This matches the definition for Director’s Dealing reports (insider transactions by directors and senior executives).
2026-05-18 English
Navamedic ASA: Mandatory notification of trade
Director's Dealing Classification · 95% confidence The document is a mandatory notification of trade by a company insider (COO Alexander Lidmejer) detailing his personal share transaction in the company. This fits the ‘Director’s Dealing’ category for insider share transactions.
2026-05-18 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.